Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: CALGB N0877 Principal Investigator: Tran, David
Title: Phase I/Randomized Phase II Trial of Either Dasatinib or Placebo Combined with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme (GBM) N0877
Phase: I/II Disease Site: Brain and Central Nervous System
Participating Site(s):
 
Main Campus
Map and Directions		 South County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to see how well dasatinib works against brain cancer when it is given in combination with temozolomide and radiation therapy.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)